<DOC>
	<DOCNO>NCT00134940</DOCNO>
	<brief_summary>The purpose observational protocol evaluate use everolimus routine clinical practice heart transplant . Primary outcome measure : incidence acute rejection episode Secondary outcome : safety</brief_summary>
	<brief_title>Post-marketing Study Collect Safety Data Heart Transplant Patients Receiving Everolimus</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Cardiac transplant recipient Discharged alive hospital Must receive everolimus Patients treat everolimus beginning within 2 week receive heart transplant Other inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Transplantation , heart</keyword>
	<keyword>Organ transplant</keyword>
</DOC>